Day: November 27, 2025

SIKA PRESENTS STRATEGIC “FAST FORWARD” PROGRAM FOR PROFITABLE GROWTH AND DIGITAL LEADERSHIPInvestments of CHF 120 to 150 million to drive digital excellence Non-recurring costs of CHF 80 to 100 million in 2025 for structural adjustments in China and efficiency measures in other markets Expected annual savings of CHF 150 to 200 million with full impact as of 2028 Strategy 2028 confirmed. Target of 3-6% sales growth in local currencies excludes market growth element Sika will present “Fast Forward”, its strategic investment and efficiency program, at today’s investor and media conference. With this comprehensive package of measures, the company is accelerating its digital transformation to increase customer value, strengthen its supply chain, and enhance operational efficiency. Sika’s leading market position is built on targeted innovations,...

The rating agency Moody’s Ratings affirmed Coop Pank’s Credit rating at current level with positive outlook. Long- and short-term deposit rating remained on the level of Baa2 and rating outlook remained positive. According to Paavo Truu, CFO of Coop Pank, the affirmation of the credit rating and positive outlook at the current level confirms that the bank is trustworthy with solid capital base, good profitability and high quality of the loan portfolio. “The affirmation of the rating and positive outlook gives private individuals and businesses additional confidence to become a customer of Coop Pank and keep their money in a domestic financial institution,” said Truu. Ratings affirmed by Moody’s Ratings for Coop Pank AS:Foreign- and local currency long- and short-term bank deposit rating Baa2/Prime-2 Long- and short-term...

SEATTLE, Nov. 26, 2025 (GLOBE NEWSWIRE) — Leafly Holdings, Inc. (“Leafly” or “the Company”), a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced that Peter Lee has been appointed Chief Executive Officer. He will remain a member of Leafly’s Board of Directors. Peter has served as Leafly’s president and Chief Operating Officer since 2024. Previously, Peter served as President, Chief Financial Officer and member of the board of directors of Merida Merger Corporation until it merged with and into Leafly as part of Leafly’s go-public transaction in 2022. Peter has been a member of Leafly’s Board of Directors ever since. From 2011 to 2018, he co-founded and was a Managing Partner at Sentinel Rock Capital, LLC, a long/short equity-oriented hedge fund. He has held various roles at other...

VANCOUVER, British Columbia, Nov. 26, 2025 (GLOBE NEWSWIRE) — Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) is pleased to announce that, in accordance with National Instrument 43-101 –  Standards of Disclosure for Mineral Projects, it has filed the technical report entitled “Diamba Sud Gold Project, Kédougou Region, Senegal”, with an effective date of October 15, 2025  (the “Technical Report”), supporting the results of the Preliminary Economic Assessment (PEA) previously announced in Fortuna’s news release dated October 15, 2025. The Technical Report is available on the Company’s website, on SEDAR+ and on EDGAR under the Company’s profile.   About Fortuna Mining Corp. Fortuna Mining Corp. is a Canadian precious metals mining company with three operating mines and a portfolio of exploration projects in Argentina, Côte d’Ivoire,...

TOKYO, JAPAN, Nov. 26, 2025 (GLOBE NEWSWIRE) — Linkage Global Inc (NASDAQ: LGCB) (“Linkage Global” or the “Company”), a cross-border e-commerce integrated services provider headquartered in Japan, is pleased to announce the pricing of a private investment in public equity (the “PIPE”) financing. On November 24, 2025, the Company entered into a securities purchase agreement pursuant to which it will issue and sell an aggregate of 689,655 Class A Ordinary Shares to an investor at a price of US$1.45 per share. The offering will result in total gross proceeds of approximately US$1,000,000 before deducting fees and offering expenses payable by the Company. Subject to customary closing conditions, the PIPE is expected to close on or before December 3, 2025. The securities will be sold in a private...

CALGARY, Alberta, Nov. 26, 2025 (GLOBE NEWSWIRE) — Quorum Information Technologies Inc. (TSX-V: QIS) (“Quorum” or the “Company”) is pleased to announce that its shareholders (the “Quorum Shareholders”) have approved a special resolution to approve a statutory plan of arrangement (the “Arrangement“) under the Business Corporations Act (Alberta) involving Quorum, the Quorum Shareholders, and 2745122 Alberta Inc. (the “Purchaser“), an affiliate of Valsoft Corporation Inc., as more particularly described in the management information circular dated October 22, 2025, which is available on SEDAR+ (www.sedarplus.ca) under Quorum’s issuer profile. Quorum Shareholders representing a total of 58,584,797 Common Shares (the “Quorum Shares“) were present in person or represented by proxy at the special meeting...

 Avante Corp. achieved 10% year-over-year revenue growth in fiscal second quarter ended September 30, 2025, driven by 47% increase in NSSG revenue, and 48% increase in Avante Black revenue.The Company achieved Adjusted EBITDA from continuing operations of $0.58 million in the fiscal second quarter, an increase of 73%, and the second quarter in a row of positive Net Income.The Company maintains a positive outlook for fiscal 2026, with expected organic growth across its services including Avante Black, HALO, Avante Verified, and MAST. TORONTO, Ontario, Nov. 26, 2025 (GLOBE NEWSWIRE) — Avante Corp. (TSX.V: XX) (OTC: ALXXF) (“Avante” or the “Company”) is pleased to announce its financial results representing the three months ended September 30, 2025 (all amounts in Canadian dollars thousands, unless otherwise indicated). Manny...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 27, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the European Society for Medical Oncology (“ESMO”) Asia Congress 2025, taking place on December 5-7, 2025 in Singapore, and the American Society of Hematology (“ASH”) Annual Meeting taking place on December 6-9, 2025 in Orlando, USA. Results from a first-in-human study of the anti-CD47 monoclonal antibody HMPL-A83 in advanced solid tumors, as well as from the phase II part of the FRUSICA-2 registration study of the fruquintinib and sintilimab combination as a second-line treatment for locally advanced or metastatic renal cell carcinoma, will be presented at the ESMO...